Cancer Supportive Care Products Market
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
<strong>Cancer</strong> <strong>Supportive</strong> <strong>Care</strong> <strong>Products</strong> <strong>Market</strong>: Global Industry<br />
Analysis and Opportunity Assessment 2016-2021<br />
January 2017<br />
Report Id : REP-GB-2550<br />
Status : Dec -2016<br />
Category : Healthcare, Pharmaceuticals & Medical Devices<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved
About<br />
Future <strong>Market</strong> Insights<br />
Future <strong>Market</strong> Insights (FMI) is a premier provider of syndicated research reports, custom<br />
research reports, and consulting services. We deliver a complete packaged solution, which<br />
combines current market intelligence, statistical anecdotes, technology inputs, valuable growth<br />
insights, aerial view of the competitive framework, and future market trends.<br />
We provide research services at a global as well as regional level; key regions include GCC,<br />
ASEAN, and BRIC.<br />
Our offerings cover a broad spectrum of industries including Chemicals, Materials, Energy,<br />
Technology, Healthcare, and Retail.<br />
We have a global presence with delivery centers across India specializing in providing global<br />
research reports and country research reports. FMI is headquartered out of London, U.K., with a<br />
state-of-the-art delivery center located in Pune, India. We combine our knowledge and learning<br />
from every corner of the world to distill it to one thing – the perfect solution for our client.<br />
Research Capabilities<br />
Sector Coverage<br />
<br />
<br />
<br />
<br />
Customized Research<br />
Syndicated Research<br />
Investment Research<br />
Social Media Research<br />
<br />
<br />
<br />
<br />
Automotive and Transportation<br />
Electronics, Semiconductor, and ICT<br />
Retail and Consumer <strong>Products</strong><br />
Industrial Automation and Equipment<br />
<br />
<br />
<br />
<br />
Chemicals & Materials<br />
Food and Beverages<br />
Services and Utilities<br />
Energy, Mining, Oil, and Gas<br />
Customized<br />
Research<br />
Syndicated<br />
Research<br />
Investment<br />
Research<br />
Social Media<br />
Research<br />
Subscription Information<br />
For detailed subscription information please contact<br />
Hari. T (Sr. Manager - Global Business Development)<br />
T: +44 (0) 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
2
Research Methodology (1/2)<br />
Systematic Research Approach<br />
<strong>Market</strong> profiling<br />
Formulating discussion guide<br />
Developing list of respondents<br />
Data collection<br />
Data validation<br />
4<br />
5<br />
3<br />
1<br />
2<br />
In-depth secondary research is used to<br />
ascertain overall market size, top<br />
industry players, top products, industry<br />
associations, etc.<br />
PMR formulates a detailed discussion<br />
guide to conduct expert and industry<br />
interviews<br />
PMR develops a list of industry players<br />
(manufacturers), distributors, retailers<br />
and industry experts<br />
PMR conducts interviews with industry<br />
experts, industry players, distributors<br />
and retailers<br />
Data is validated by triangulation<br />
method, wherein secondary, primary<br />
and PMR analysis contribute to the final<br />
data<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
<br />
Data<br />
Collection<br />
Data Filter<br />
& Analysis<br />
Identifying key opinion leaders<br />
Questionnaire design<br />
In-depth interviews<br />
Coverage across value chain<br />
<strong>Market</strong> participants<br />
Key strengths<br />
Product portfolio<br />
Mapping as per value chain<br />
Key focus segments<br />
A<br />
Primary<br />
Research<br />
C<br />
Company<br />
Analysis<br />
Research &<br />
Intelligence<br />
SOLUTION<br />
Actionable<br />
Insights<br />
B<br />
Desk<br />
Research<br />
<br />
<br />
<br />
<br />
<br />
<br />
Business<br />
Solution<br />
Key industry experts<br />
Channel study<br />
Developments<br />
<strong>Market</strong> dynamics<br />
<strong>Products</strong><br />
Conclusions<br />
Data analysis<br />
6<br />
Data is scrutinized using MS-Excel to<br />
obtain qualitative and quantitative<br />
insights about the industry<br />
Primary Research #<br />
Secondary Research #<br />
Paid Publications#<br />
Insights<br />
7<br />
PMR delivers industry insights and<br />
information in the required format<br />
(PDF)<br />
<br />
<br />
<br />
<br />
Linkedin<br />
Zoominfo<br />
Salesforce<br />
Avention<br />
<br />
<br />
<br />
<br />
Company websites<br />
Company annual<br />
reports<br />
White papers<br />
Financial reports<br />
<br />
<br />
<br />
<br />
Factiva<br />
GBI<br />
Genios<br />
Meltwater<br />
# includes sources of databases<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
3
<strong>Cancer</strong> <strong>Supportive</strong> <strong>Care</strong> <strong>Products</strong> <strong>Market</strong><br />
<strong>Cancer</strong> <strong>Supportive</strong> <strong>Care</strong> <strong>Products</strong> <strong>Market</strong> to Witness Steady Growth, Demand for Erythropoietin<br />
Stimulating Agents to Escalate over 2016-2021<br />
Rising prevalence of cancers and adverse effects cases during cancer treatment will remain the most<br />
prominent factor driving the demand for cancer supportive care products on a global level. FMI indicates<br />
steady growth prospects for the global cancer supportive care products market over 2016-2021. The<br />
market is likely to reach US$ 25.35 Bn in 2016. Erythropoietin stimulating agents will register the highest<br />
consumption. North America is expected to retain the largest market.<br />
Growing prominence of cancers is anticipated to spur the demand for supportive care. In addition, rising<br />
incidences of side-effects of anti-cancer therapy and superior results of existing anti-cancer drugs will<br />
collectively propel consumption of cancer supportive care products globally. Awareness about the usage<br />
of supportive care in cancer treatment, especially in developing countries, will also be a key factor<br />
highlighting the growing popularity of cancer supportive care products. Government initiatives regarding<br />
improved healthcare infrastructure, rising R&D investments, and augmenting healthcare spending are<br />
identified to be the major factors positively impacting the market growth. Since the past few years,<br />
innovative drug development has been on the priority for leading manufacturers. This is predicted to be a<br />
booster to the demand for cancer supportive care products.<br />
Request For Report Sample: http://www.futuremarketinsights.com/reports/sample/rep-gb-2550<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 4
<strong>Cancer</strong> <strong>Supportive</strong> <strong>Care</strong> <strong>Products</strong> <strong>Market</strong><br />
However, high costs and inadequate reimbursement policies will remain longstanding challenges to the<br />
market growth. Moreover, promising entry of biosimilar drugs and loss of generic drugs brand exclusivity<br />
may also detain the market post-2016.<br />
By drug class, the global cancer supportive care products market has eight key segments i.e. nonsteroidal<br />
anti-inflammatory drugs, anti-infective, anti-emetics, monoclonal antibodies, erythropoietin<br />
stimulating agents, opioid analgesics, bisphosphonates, and granulocyte colony stimulating factors.<br />
Erythropoietin stimulating agents segment will continue to dominate with over 24% value share in 2016.<br />
Granulocyte colony stimulating factors will however be the second largest segment with almost 20%<br />
market share by 2016 end.<br />
Based on disease indication, lung cancer will continue to dominate other segments, including melanoma,<br />
leukemia, breast cancer, liver cancer, prostate cancer, bladder cancer, ovarian cancer, and others. Breast<br />
cancer segment is likely to emerge at the highest growth rate. This growth is attributed to increasing<br />
cases of genetic inheritance, evolving lifestyle of women, and rising adoption of hormone replacement<br />
therapy.<br />
On the basis of distribution channel, the market is classified into three key segments viz. hospital<br />
pharmacies, retail pharmacies, and compounding pharmacies.<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 5
<strong>Cancer</strong> <strong>Supportive</strong> <strong>Care</strong> <strong>Products</strong> <strong>Market</strong><br />
By geography, North America will remain the key market with over 43% market value share, followed by<br />
Europe with around 20% share by 2016, in terms of revenues. However, APAC is expected to witness at<br />
the fastest growth rate, creating the most lucrative market.<br />
The key players participating in the global cancer supportive care products marketplace, include Baxter<br />
International Inc, Novartis Ag., Johnson & Johnson, Amgen Inc., Hoffmann LA- Roche Ltd, APR Applied<br />
Pharma Science Research S.A., Teva Pharmaceuticals Industries Ltd, Fagron Group BV, Acacia Pharma Ltd.,<br />
and Kyowa Hakko Kirin Co Ltd. Leading manufacturers are increasingly concentrating on developing new<br />
supportive care products to stand out from competition.<br />
Long-term Outlook: Over 2016-2021, the global market for cancer supportive care products is poised to<br />
expand at a CAGR of around 4.5%, reaching a value of US$ 29.87 Bn by 2021 end.<br />
Click here to<br />
Order a free sample<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved 6
Table of Content<br />
1. Executive Summary<br />
2. Research Methodology<br />
3. Assumption & Acronyms Used<br />
4. <strong>Market</strong> Overview<br />
4.1. Parent <strong>Market</strong> Overview<br />
4.2. <strong>Market</strong> Taxonomy & <strong>Market</strong> Definition<br />
4.3. Global <strong>Cancer</strong> <strong>Supportive</strong> <strong>Care</strong> <strong>Products</strong> <strong>Market</strong> Size and Forecast<br />
4.3.1. Introduction<br />
4.3.2. <strong>Market</strong> Value Forecast & Y-o-Y Growth Rate (2015-2021)<br />
4.4. Global <strong>Cancer</strong> <strong>Supportive</strong> <strong>Care</strong> <strong>Products</strong> <strong>Market</strong> Dynamics<br />
4.4.1. Drivers<br />
4.4.2. Restraints<br />
4.4.3. Trends<br />
4.4.4. Opportunity<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
7
Table of Content<br />
5. Regulations & PEST Analysis<br />
6. Global <strong>Cancer</strong> <strong>Supportive</strong> <strong>Care</strong> <strong>Products</strong> <strong>Market</strong> Analysis and Forecast By Drug Class<br />
6.1. Introduction<br />
6.1.1. Introduction<br />
6.1.2. Y-o-Y Growth Comparison, By Drug Class<br />
6.1.3. BPS Analysis, By Drug Class<br />
6.1.3.1. Nonsteroidal Anti-inflammatory Drugs<br />
6.1.3.2. Anti-infective<br />
6.1.3.3. Anti-emetics<br />
6.1.3.4. Monoclonal Antibodies<br />
6.1.3.5. Erythropoietin Stimulating Agents<br />
6.1.3.6. Opioid Analgesics<br />
6.1.3.7. Bisphosphonates<br />
6.1.3.8. Granulocyte Colony Stimulating Factor<br />
6.1.4. Global <strong>Cancer</strong> <strong>Supportive</strong> <strong>Care</strong> <strong>Products</strong> <strong>Market</strong> Attractiveness Analysis By Drug Class<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
8
Table of Content<br />
7. Global <strong>Cancer</strong> <strong>Supportive</strong> <strong>Care</strong> <strong>Products</strong> <strong>Market</strong> Analysis and Forecast By Indication<br />
7.1. Introduction<br />
7.1.1. Y-o-Y Growth Comparison, By Indication<br />
7.1.2. BPS Analysis, By Indication<br />
7.1.2.1. Lung <strong>Cancer</strong><br />
7.1.2.2. Breast <strong>Cancer</strong><br />
7.1.2.3. Prostate <strong>Cancer</strong><br />
7.1.2.4. Liver <strong>Cancer</strong><br />
7.1.2.5. Bladder <strong>Cancer</strong><br />
7.1.2.6. Leukaemia<br />
7.1.2.7. Ovarian <strong>Cancer</strong><br />
7.1.2.8. Melanoma<br />
7.1.2.9. Other <strong>Cancer</strong><br />
7.1.3. Global <strong>Cancer</strong> <strong>Supportive</strong> <strong>Care</strong> <strong>Products</strong> <strong>Market</strong> Attractiveness Analysis By Indication<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
9
Table of Content<br />
8. <strong>Cancer</strong> <strong>Supportive</strong> <strong>Care</strong> <strong>Products</strong> <strong>Market</strong> Analysis and Forecast By Distribution Channel<br />
8.1. Introduction<br />
8.1.1. Y-o-Y Growth Comparison, By Distribution Channel<br />
8.1.2. BPS Analysis, By Distribution Channel<br />
8.1.2.1. Hospital Pharmacies<br />
8.1.2.2. Retail Pharmacies<br />
8.1.2.3. Compounding Pharmacies<br />
8.1.3. Global <strong>Cancer</strong> <strong>Supportive</strong> <strong>Care</strong> <strong>Products</strong> <strong>Market</strong> Attractiveness Analysis By<br />
Distribution Channel<br />
Click here to<br />
Order a free sample<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
10
To know more about us, please visit our website:<br />
www.futuremarketinsights.com<br />
For sales queries or new topics email us on:<br />
sales@futuremarketinsights.com<br />
For media queries, contact the press office at<br />
press@futuremarketinsights.com<br />
For other queries contact:<br />
Hari. T (Sr. Manager - Global Business Development)<br />
Future <strong>Market</strong> Insights: 3rd Floor,<br />
207 Regent Street, London W1B 3HH<br />
T: +44 20 7692 8790 | D: +44 20 3287 4268<br />
Email: hari.t@futuremarketinsights.com<br />
Thank You<br />
Future <strong>Market</strong> Insights Global & Consulting Private Limited (FMI)<br />
©2015 Future <strong>Market</strong> Insights, All Rights Reserved<br />
11
Change language